Teladoc Health (TDOC) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Teladoc Health (NYSE: TDOC):

• 11/25/2025 – Teladoc Health had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Teladoc Health had its price target lowered by analysts at Bank of America Corporation from $9.00 to $8.00. They now have a “neutral” rating on the stock.
• 11/13/2025 – Teladoc Health is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $8.00 price target on the stock.
• 11/10/2025 – Teladoc Health was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 10/30/2025 – Teladoc Health had its price target lowered by analysts at Evercore ISI from $9.00 to $8.00. They now have an “in-line” rating on the stock.
• 10/21/2025 – Teladoc Health had its price target raised by analysts at Citigroup Inc. from $9.50 to $10.50. They now have a “neutral” rating on the stock.
• 10/10/2025 – Teladoc Health was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 10/8/2025 – Teladoc Health had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 10/8/2025 – Teladoc Health had its price target raised by analysts at Evercore ISI from $8.00 to $9.00. They now have an “in-line” rating on the stock.

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.